ELTXElicio Therapeutics, Inc.vs its industry peers
A metric-by-metric comparison of Elicio Therapeutics, Inc. against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Empresa | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ELTXEsta | $41M#7 | — | 5.1x#10 | 17.6x#4 | -91.9%#6 | 23.8%#5 | -1639.0%#4 | -498.6%#11 | — | — | -83.3%#9 | — |
| ANVS | $48M#1 | — | — | — | — | -17.3%#8 | — | — | — | — | -44.7%#7 | — |
| SKYE | $47M#2 | — | — | — | — | -110.5%#11 | — | — | — | — | -89.0%#13 | — |
| AZTR | $47M#3 | 39.0x#4 | 6.4x#11 | — | -100.0%#7 | -22.2%#9 | — | -149.4%#9 | — | — | -83.8%#10 | — |
| SER | $47M#4 | — | — | 361.5x#6 | 132.1%#2 | -72.2%#10 | -18478.5%#6 | — | — | 5#2 | -61.7%#8 | — |
| YARW | $46M#5 | 2.0x#1 | 2.1x#8 | 81.4x#5 | 13.8%#3 | 33.5%#4 | -5219.1%#5 | -120.0%#8 | — | — | 1.9%#2 | — |
| ATNM | $46M#6 | 4.2x#2 | 1.5x#7 | 510.0x#7 | — | 11.4%#7 | -40274.4%#7 | -111.8%#7 | — | — | 6.6%#1 | — |
| APUS | $4M#14 | — | 0.0x#1 | — | — | -331.7%#12 | — | -5.6%#1 | -11.2%#1 | — | -88.8%#12 | — |
| SCYX | $39M#8 | 13.9x#3 | 0.6x#2 | 1.9x#2 | 449.9%#1 | 59.6%#1 | -78.0%#2 | -12.9%#2 | — | 7#1 | -24.2%#4 | — |
| VERU | $37M#9 | — | 1.3x#6 | 2.2x#3 | 3.6%#4 | 39.9%#2 | -146.6%#3 | -80.1%#4 | -399.3%#4 | — | -15.8%#3 | 0.0%#1 |
| NNVC | $37M#10 | — | 4.2x#9 | — | — | 13.2%#6 | — | -94.7%#6 | -78.2%#3 | — | -28.8%#5 | — |
| ALDX | $37M#11 | — | 1.0x#5 | — | — | 39.4%#3 | — | -89.3%#5 | — | — | -88.4%#11 | — |
| LITS | $32M#12 | — | 0.8x#3 | — | -100.0%#7 | -346.2%#13 | — | -170.9%#10 | — | — | -44.5%#6 | — |
| RMTI | $32M#13 | 261.3x#5 | 0.9x#4 | 0.5x#1 | -31.8%#5 | -1007.1%#14 | -6.8%#1 | -15.1%#3 | -14.0%#2 | 4#3 | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. Esta tabla agotó el tiempo durante su construcción, por lo que cubre parte del grupo; los rangos son solo dentro de las filas mostradas y se completará en breve. Table built 2026-11-03.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice